| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
-Chain Messenger Ribonucleic Acids That Are Regulated by GnRH in Vitro1
Department of Obstetrics and Gynecology, National Taiwan University Hospital (H.-F.C.), Taipei, Taiwan; the Laboratory of Veterinary Biochemistry, Chungbuk National University (E.-B.J.), Cheong-ju, Korea; and the Department of Obstetrics and Gynecology, University of British Columbia (M.S., P.C.K.L.), Vancouver, British Columbia, Canada V6H 3V5
Address all correspondence and requests for reprints to: Dr. P. C. K. Leung, Department of Obstetrics and Gynecology, 4490 Oak Street, Vancouver, British Columbia, Canada V6H 3V5. E-mail: peleung{at}unixg.ubc.ca
The hypothalamic decapeptide, GnRH, plays a critical role in human
reproduction. In addition to the well known effects of GnRH on
pituitary cells, there is evidence supporting the presence of
GnRH-binding sites in tissues other than pituitary cells, including
lymphocytes. In addition, a GnRH-like substance has been found to be
secreted from lymphoid cells. However, the precise nature of GnRH
secretion and binding in immune cells has not been fully established.
In this study, we used the RT-PCR method to examine the expression and
regulation of GnRH, GnRH receptor (GnRHR), and interleukin-2 receptor
-chain messenger ribonucleic acids (mRNAs) in human peripheral blood
mononuclear cells. It was found that human mononuclear cells expressed
GnRH and GnRHR mRNAs. Nucleotide sequences of these mRNAs are identical
to their hypothalamic and pituitary counterparts, respectively. In
addition, GnRH and GnRHR mRNA expressions in peripheral blood
mononuclear cells are regulated by GnRH and its synthetic analogs
in vitro. Treatment with various concentrations of GnRH
(10-5-10-11 mol/L) increased GnRHR mRNA
expression in a dose-dependent manner (maximal level is 158% of the
untreated control value at 10-8 mol/L GnRH;
P < 0.05), but reduced GnRH mRNA levels to 69% of
the untreated control value at 10-9 mol/L GnRH
(P < 0.05). Cotreatment of GnRH with a GnRH
antagonist blocked these regulatory effects, indicating the
receptor-mediated nature of the GnRH action. Both GnRH and GnRH
agonist stimulated interleukin-2 receptor
-chain mRNA in a
dose-dependent manner, indicating that GnRH may be involved in
lymphocyte activation. In summary, these observations suggest that
mRNAs encoding the pituitary form of GnRHR and the hypothalamic form of
GnRH are also expressed in human peripheral blood mononuclear cells.
The endogenous production of GnRH by lymphocytes may act as an
autocrine or paracrine factor to regulate immune functions. Because of
the presence of GnRHR on lymphocytes, exogenous GnRH analog therapy may
have an impact on the immune system through these receptors.
This article has been cited by other articles:
![]() |
J. S. Sutherland, L. Spyroglou, J. L. Muirhead, T. S. Heng, A. Prieto-Hinojosa, H. M. Prince, A. P. Chidgey, A. P. Schwarer, and R. L. Boyd Enhanced Immune System Regeneration in Humans Following Allogeneic or Autologous Hemopoietic Stem Cell Transplantation by Temporary Sex Steroid Blockade Clin. Cancer Res., February 15, 2008; 14(4): 1138 - 1149. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Montgomery Distribution and Cellular Heterogeneity of Bovine Viral Diarrhea Viral Antigen Expression in the Brain of Persistently Infected Calves: A New Perspective Vet. Pathol., September 1, 2007; 44(5): 643 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lutton and I. Callard Evolution of reproductive-immune interactions Integr. Comp. Biol., December 1, 2006; 46(6): 1060 - 1071. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Salazar, M. R. Miller, J. B. Barnett, and R. Schafer Evidence for a Novel Endocrine Disruptor: The Pesticide Propanil Requires the Ovaries and Steroid Synthesis to Enhance Humoral Immunity Toxicol. Sci., September 1, 2006; 93(1): 62 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
J S. Mohamed and I A Khan Molecular cloning and differential expression of three GnRH mRNAs in discrete brain areas and lymphocytes in red drum. J. Endocrinol., March 1, 2006; 188(3): 407 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Silver, N. V. Nucci, A. R. Root, K. L. Reed, and S. A. Sower Cloning and Characterization of a Functional Type II Gonadotropin-Releasing Hormone Receptor with a Lengthy Carboxy-Terminal Tail from an Ancestral Vertebrate, the Sea Lamprey Endocrinology, August 1, 2005; 146(8): 3351 - 3361. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Cheng and P. C. K. Leung Molecular Biology of Gonadotropin-Releasing Hormone (GnRH)-I, GnRH-II, and Their Receptors in Humans Endocr. Rev., April 1, 2005; 26(2): 283 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Delgado, D. Pozo, and D. Ganea The Significance of Vasoactive Intestinal Peptide in Immunomodulation Pharmacol. Rev., June 1, 2004; 56(2): 249 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Jacobson and M. A. Ansari Immunomodulatory Actions of Gonadal Steroids May Be Mediated by Gonadotropin-Releasing Hormone Endocrinology, January 1, 2004; 145(1): 330 - 336. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. D. Dixit, H. Yang, V. Udhayakumar, and R. Sridaran Gonadotropin-Releasing Hormone Alters the T Helper Cytokine Balance in the Pregnant Rat Biol Reprod, June 1, 2003; 68(6): 2215 - 2221. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. D. Dixit, R. Sridaran, M. A. Edmonsond, D. Taub, and W. E. Thompson Gonadotropin-Releasing Hormone Attenuates Pregnancy-Associated Thymic Involution and Modulates the Expression of Antiproliferative Gene Product Prohibitin Endocrinology, April 1, 2003; 144(4): 1496 - 1505. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Chou, H. Zhu, E. Shalev, C. D. MacCalman, and P. C. K. Leung The Effects of Gonadotropin-Releasing Hormone (GnRH) I and GnRH II on the Urokinase-Type Plasminogen Activator/Plasminogen Activator Inhibitor System in Human Extravillous Cytotrophoblasts in Vitro J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5594 - 5603. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. G. Silveira, P. M. Stewart, M. Thomas, D. A. Clark, P. M. G. Bouloux, and G. S. MacColl Novel Homozygous Splice Acceptor Site GnRH Receptor (GnRHR) Mutation: Human GnRHR "Knockout" J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2973 - 2977. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Pincas, K. Amoyel, R. Counis, and J.-N. Laverrière Proximal cis-Acting Elements, Including Steroidogenic Factor 1, Mediate the Efficiency of a Distal Enhancer in the Promoter of the Rat Gonadotropin-Releasing Hormone Receptor Gene Mol. Endocrinol., February 1, 2001; 15(2): 319 - 337. [Abstract] [Full Text] |
||||
![]() |
P. Bull, P. Morales, C. Huyser, T. Socias, and E.A. Castellon Expression of GnRH receptor in mouse and rat testicular germ cells Mol. Hum. Reprod., July 1, 2000; 6(7): 582 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Cheng, P. S. Nathwani, and P. C. K. Leung Regulation of Human Gonadotropin-Releasing Hormone Receptor Gene Expression in Placental Cells Endocrinology, July 1, 2000; 141(7): 2340 - 2349. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. JACOBSON Gonadotropin-Releasing Hormone and G Proteins: Potential Roles in Autoimmunity Ann. N.Y. Acad. Sci., January 1, 2000; 917(1): 809 - 818. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Jacobson, M. A. Ansari, M. Kinealy, and V. Muthukrishnan Gender-Specific Exacerbation of Murine Lupus by Gonadotropin-Releasing Hormone: Potential Role of G{alpha}q/11 Endocrinology, August 1, 1999; 140(8): 3429 - 3437. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |